Lymphaticovenular anastomosis for lymph vessel injury in the pelvis and groin
-
- Hideki Kadota
- Department of Plastic and Reconstructive Surgery Kyushu University Hospital Fukuoka Japan
-
- Ryo Shimamoto
- Department of Plastic and Reconstructive Surgery Kyushu University Hospital Fukuoka Japan
-
- Seita Fukushima
- Department of Plastic and Reconstructive Surgery Kyushu University Hospital Fukuoka Japan
-
- Yusuke Inatomi
- Department of Plastic and Reconstructive Surgery Kyushu University Hospital Fukuoka Japan
-
- Ko Ikemura
- Department of Plastic and Reconstructive Surgery Kyushu University Hospital Fukuoka Japan
-
- Kayo Miyashita
- Department of Plastic and Reconstructive Surgery Kyushu University Hospital Fukuoka Japan
-
- Kenichi Kamizono
- Department of Plastic and Reconstructive Surgery Kyushu University Hospital Fukuoka Japan
-
- Masuo Hanada
- Department of Plastic and Reconstructive Surgery Kyushu University Hospital Fukuoka Japan
-
- Sei Yoshida
- Department of Plastic and Reconstructive Surgery Kyushu University Hospital Fukuoka Japan
この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Lymphatic diseases due to lymph vessel injuries in the pelvis and groin require immediate clinical attention when conventional treatments fail. We aimed to clarify the effectiveness of and indications for lymphaticovenular anastomosis (LVA) to treat these lymphatic diseases.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We retrospectively evaluated six patients who underwent LVA for lymphatic diseases due to lymph vessel injuries in the pelvis and groin. Specific pathologies included groin lymphorrhea (<jats:italic>N</jats:italic> = 3), chylous ascites (<jats:italic>N</jats:italic> = 2), and retroperitoneal lymphocele (<jats:italic>N</jats:italic> = 1). The maximum lymphatic fluid leakage volume was 150–2600 mL daily. Conventional treatments (compression, drainage, fasting, somatostatin administration, negative pressure wound therapy, or lymph vessel ligation) had failed to control leakage in all cases. We performed lower extremity LVAs after confirming the site of lymph vessel injury using lymphoscintigraphy. We preferentially placed LVAs in thigh sites that showed a linear pattern by indocyanine green lymphography. Postoperative lymphatic fluid leakage volume reduction was evaluated, and leakage cessation was recorded when the drainage volume approached 0 mL.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>LVA was performed at an average of 4.3 sites (range, 3–6 sites) in the thigh and 2.7 sites (range, 0–6 sites) in the lower leg. Lymphatic fluid leakage ceased in all cases after a mean of 6 days (range, 1–11 days) postoperatively. No recurrence of symptoms was observed during an average follow‐up of 2.9 (range, 0.5–5.5) years.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>LVA demonstrates excellent and rapid effects. We recommend lower extremity LVA for the treatment of lymphatic diseases due to lymph vessel injuries in the pelvis and groin.</jats:p></jats:sec>
収録刊行物
-
- Microsurgery
-
Microsurgery 41 (5), 421-429, 2021-04-03
Wiley
